The PennZone

  • Home
  • Non-profit
  • Technology
  • Education
  • Construction
  • Business
  • Entertainment
  • Health
  • Software

The Advocate Selected to Participate in Reuters Pharma & Patients 2022
The PennZone/10206754

Trending...
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Thou Shalt not Commit Adultery Lifetime Movie Discussion
Reuters Pharma & Patients Conference 2022 The Advocate, working together with patient advocacy, professional associations/societies and pharmaceutical companies, hand-in-hand. (PRNewsfoto/The Advocate: Supporting the Patient Voice)
The Advocate Set To Detail of Pharma Manufacturers Work with Them to Manage Internal Leaders to Drive Change

WEST CHESTER, Pa., Oct. 31, 2022 /PRNewswire/ -- The Advocate: Supporting the Patient Voice is proud to announce it's Editor-in-Chief & Head of Advocacy Engagement, Matt Toresco, has been asked to speak at the Reuters Pharma and Patients Conference 2022. This year's conference is dedicated to both the clinical and commercial ends of the pharmaceutical manufacturer, to challenge the manufacturer to engage in new ways with patient advocates and patients to drive systemic change.

"I am proud to represent The Advocate and patient voices to the audience at Reuters in The Brooks Group's backyard of Philadelphia, from November 8th and 9th," Matt noted. "This [Reuters] opportunity allows us to tell the story of our partners and how they have used our data sets year over year to identify opportunities to better engage with patients and make true paradigm shifts within their organization." Matt was truly choked up when he noted, "It's humbling to have had the opportunity to hear these stories from our partners, true partners that have stuck with me through my own medical challenges over the last few months." He confined, "but we feel even more empowered to add more customers to continue to drive true outcomes for patients while laying out some key issues we see evolving over the last 7 years leaving patients in difficult spots."

More on The PennZone
  • Tru by Hilton El Paso Airport Opens to Guests
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Christian Apocalyptic Thriller Explores Biblical Prophecy, Global Technology, & the Rise of the Ant
  • Turnstone Creative Expands Leadership Team with Addition of Marketing Manager

You can find out more about the Reuters Pharma & Patients 2022 Conference taking place at the Old City Marriott in Philadelphia, November 8th & 9th at the conference's website at:  Reuters Patient & Pharma USA 2022

You can also reach out directly to Matt and the team at The Advocate through their website at https://theadvocatepatientvoice.com, on twitter at @The_Advocate_PV, or through email at [email protected].

SOURCE The Advocate: Supporting the Patient Voice
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Speaker and Certified Coach Syrena N. Williams Debuts Powerful New Book on Healing, Identity, and Wholeness
  • Lord of the Rings, Doctor Who' Q&As, Local Sessions Highlight FAN EXPO Philadelphia Programming
  • Kryptokasinot.io Raises Concerns Over Proposed Cryptocurrency Restrictions in Finland's Gambling Reform
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • The Calida Group Announces Sale of Ely at Fort Apache for $57.5 Million
  • Tina Hasselbusch, co-founder and CEO of Turnstone Creative, Receives Circle of Excellence from Lehigh Valley Business
  • Summer Festivals in Gunma Prefecture: Song, Dance, and Vibrant Color – Get There Via Tobu Railway!
  • Jetperch Introduces Joulescope JS320 Precision Energy Analyzer for Low-Power Embedded System Development
  • AI-Powered Trading Bots Are Transforming Forex, Gold, and Digital Markets as DefiHash Expands Intelligent Quantitative Infrastructure
  • Early Bird Registration Open for FLYING HY, the Top Hydrogen and Battery Electric Aviation Event
  • Eichelberger Performing Arts Center Welcomes New Executive Director
  • Century Fasteners Corp. Hires Tony Marano as Director of Human Resources
  • Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
  • New Wisconsin Report Shows Most Plane Crashes Happen Outside Major Hubs
  • Thou Shalt not Commit Adultery Lifetime Movie Discussion
  • Book Florida Keys Accommodations Early with KeysCaribbean and Save 15 Percent
  • Color Card Administrator Highlights Growing Enterprise Demand for Workflow Orchestration in Enterprise Business Card Governance
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Curious About Mensa? DFW Event Offers a 1-Day Immersion
  • Morphy's will breeze into summer with a June 10-11 Fine & Decorative Arts auction featuring nearly 1,200 high-quality lots

Popular on PennZone

  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • "I'm Sicka Church Too: Give Me Kingdom!" Ignites a Powerful Call for Healing and Truth
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • BTR: i2 Group Launches i2 Amplify, a Community Platform for Intelligence Professionals Worldwide
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding

Similar on PennZone

  • AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
  • UK Financial Ltd Audits Full Ethereum Architecture Verifies Corporate Wallets and 19-Token Ecosystem Ahead of CoinMarketCap Filing for Global Ranking
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • TechHouse Earns Highly Selective Microsoft Support Badge
  • J&J Exterminating Celebrates 65th Anniversary and Unveils Strategic Vision at Annual Team Meeting
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Milton Collier, CEO & President of Freight Broker 911, Eliminates the #1 Barrier to Entry in Logistics: Announces 100% Free Freight Broker Training
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
  • Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us